Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v4-FR | Version v3-EN | |
---|---|---|
Language | French | English |
Date Updated | 2021-03-24 | 2021-03-24 |
Drug Identification Number | 02204266 | 02204266 |
Brand name | DEXAMETHASONE-OMEGA | DEXAMETHASONE-OMEGA |
Common or Proper name | Dexamethasone Sodium Phosphate Injection USP | Dexamethasone Sodium Phosphate Injection USP |
Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
Ingredients | DEXAMETHASONE PHOSPHATE | DEXAMETHASONE PHOSPHATE |
Strength(s) | 4MG | 4MG |
Dosage form(s) | LIQUID | LIQUID |
Route of administration | INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SOFT TISSUE INJECTION INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SOFT TISSUE INJECTION | INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SOFT TISSUE INJECTION INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SOFT TISSUE INJECTION |
Packaging size | 5 x 5mL vial / fiole | 5 x 5mL vial / fiole |
ATC code | H02AB | H02AB |
ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
Anticipated start date | ||
Actual start date | 2020-06-18 | 2020-06-18 |
Estimated end date | Unknown | Unknown |
Actual end date | 2021-03-01 | 2021-03-01 |
Shortage status | Resolved | Resolved |
Tier 3 Status | No | No |
Company comments | On allocation for Covid. | On allocation for Covid. |
Health Canada comments |